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Of the 24 males identified as having fragile X syndrome in the Northeast Essex screening programme, 25% had epilepsy.
Epilepsy in individuals with fragile X syndrome is known to follow a benign course with seizures disappearing before the age
of 20. However, half of our sample with a history of epilepsy continued to have seizures after the age of 20.
We reviewed the EEG reports of 18 of the 24 individuals (aged between 13 and 63 years) including all six individuals with
epilepsy. We had 32 EEG recordings from 18 subjects, with nine people having more than one recording at different points. The
EEG showed a definite improvement in only five individuals. Three individuals who had serial recordings (one with epilepsy)
showed no significant changes over time and the EEG of one subject with epilepsy deteriorated.
The most common abnormal EEG findings were rhythmic theta activity (50%) and a slowing of background activity (28%).
There were no characteristic features in the sleep EEGs performed on four subjects. The possible implications of these prelimi-
nary findings are discussed.
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INTRODUCTION
Fragile X syndrome is the most common cause of
mental retardation after Down syndrome. It affects ap-
proximately 1 in 4000 (0.25/1000) males and 1 in 8000
(0.125/1000) females1, 2. The prevalence of epileptic
seizures in fragile X syndrome is lower than that in
individuals with developmental disability due to other
causes but considerably higher than that in the general
population3. The actual prevalence of seizures as re-
ported by studies vary from 14% to 50% with a mean
around 22%4, 5.
The natural history of epilepsy in fragile X syn-
drome has been described as generalized seizures oc-
curring in the first 15 years of life, responding well
to anticonvulsants, particularly to carbamazepine, and
disappearing after adolescence5. This typical benign
course is questioned by the reports of epilepsy in older
people with fragile X syndrome23.
EEG findings in fragile X have been reported in
a number of studies10, 16. Although no characteristic
EEG changes were noticed initially, a distinct pattern
was later identified20, 22, 23.
The present study examines the clinical features of
epilepsy and the EEG abnormalities in a cohort of
24 males with fragile X syndrome. We further discuss
the findings from this study in the context of the find-
ings from the previous studies.
MATERIALS AND METHODS
This study was undertaken after obtaining the ap-
proval of the Local Research Ethical Committee. The
sample of this study was identified in the Northeast
Essex screening programme, which on the basis of cy-
togenetic screening identified a total of 24 males and
one female in the North Essex region as having fragile
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Table 1: EEG findings in fragile X males in the literature.
Epilepsy findings EEG findings
Reference Year Epileptic Epilepsy No. of Normal Diffuse Excess Epileptic Focal No. of
subjects/ rate patients pattern slowing rhythmic discharges discharges epileptic
Total subjects studied by background theta patients
EEG activity activities
Wisnewski5 1991 14/62 23% 36 — — 18 3 — 14
Lubs6 1968 1/4 25% — — — — — — —
Escalante et al.7 1971 2/9 22% — — — — — — —
Turner et al.8 1975 1/7 14% — — — — — — —
Harvey et al.9 1977 4/20 20% — — — — — — —
Brown et al.10 1978 2/6 33% 4 — — — — — 2
Labrisseau et al.11 1982 2/7 29% 4 — 3 — 2 — 2
Gardner et al.12 1983 1/8 13% 1 — — — — 1 1
Brondum-Nielsen13 1983 4/25 16% — — — — — — —
Jacobs et al.14 1983 1/5 20% 1 — 1 — — — 1
Fryns15 1985 4/44 9% — — — — — — —
Wisnewski et al.16 1985 7/28 25% 10 6 1 — 3 3 3
Finelli et al.17 1985 7/16 44% 2 — 1 — 1 1 2
Sanfillipo et al.18 1986 3/4 75% 3 — 3 — (3) — 3
Veenema et al.19 1987 5/14 36% — — — — — — —
Musumeci20 1988 6/12 50% — — — — — — —
Vieregge21 1989 4/29 14% 12 4 6 — 3 1 1
Musumeci22 1991 8/18 44% 18 — 13 — 5 — —
X syndrome24. The diagnosis was later confirmed in
1996 using Southern Blot techniques.
Using a 16-channel sleep model EEG machine
and applying electrodes according to the international
10–20 system for positions as previously described25,
EEG recordings were taken from 18 of the 24 iden-
tified male patients. The present EEG reports were
compared with the previous reports in nine individu-
als with multiple EEGs.
RESULTS
The 24 males included in this study varied from 13 to
63 years of age.
Epilepsy
Six out of 24 people had epileptic seizures, three with
primary generalized epilepsy and the other three with
focal epilepsy of temporal origin (associated with sec-
ondary generalization). While the onset of epilepsy
was identified in three people under the age of 5, it was
under the age of 20 in one person and 50 in another.
The age of onset was unknown in one patient.
Three people in this sample stopped having seizures
by the age of 20 and one at an unknown age after 20.
One person, aged 27, continues to have seizures de-
spite anticonvulsant medication, and the one with late
onset seizures is controlled on anticonvulsant medica-
tion.
Table 2: EEG review results: features seen in 32 EEGs on
18 subjects.
Rhythmic theta 14/32 43.75%
Slow alpha/background 10/32 31.25%
Paroxysmal slow episodes 10/32 31.25%
Normal alpha ?18/32 56.25%
Sharp/spike discharges 8/32 25%
Sleep phenomena 4/32 12.5%
EEG findings
A total of 34 EEG recordings were available from
the 18 subjects, with nine subjects having more than
one EEG (Table 2). Five of the six individuals with
epilepsy (83%) had more than one EEG. The ages
when recordings were made ranged from 3 to 66 years,
with a mean age of 29.15.
Only five out of 18 subjects had a normal EEG. A
rhythmic theta activity was noted in half of the sam-
ple (9/18). It was bilateral, usually between 5–7 c/s,
and often of highest amplitude over precentral/frontal
or temporal regions. In individuals with this theta ac-
tivity, it was seen consistently in all the reports when
serial recordings were available.
In several EEGs alpha activity was scanty (7–21%),
dominated by widespread background activity or more
prominent (slower) rhythmic activity. Slowing of the
alpha rhythm and background activity was evident in
five individuals (27.7%). Episodes of high amplitude
slow activity were seen in four individuals (22%), but
three of these were children.
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When compared with the EEGs taken when the sub-
jects were younger, only four of nine (44%) showed
improvement. Two of these had a history of epilepsy.
Four individuals including two with epilepsy (44%)
showed no change and one who had late onset epilepsy
showed deterioration (12%).
While two of the individuals with focal epilepsy had
activity in the left temporal region, one had activity
on the right side. A non-epileptic individual had sharp
spikes on the EEG. He was on 10 mg haloperidol per
day.
Four individuals, two of them with epilepsy and two
without epilepsy, had a daytime drug-free sleep EEG.
Only two individuals in this group showed abnormali-
ties in the sleep EEG, one with epilepsy had episodes
of central slowing whilst the one without the clinical
epilepsy showed bilateral slow activity.
DISCUSSION
The prevalence of epileptic seizures in this study is
25% (6/24) among the males. This is similar to the
findings from the previous studies (Table 1).
Wisniewski5 reported that seizures in fragile X syn-
drome are usually generalized. However, in this study
half of the sample with epileptic seizures had focal
epilepsy of temporal origin with secondary general-
ization (3/6). Temporal lobe seizures, especially those
originating on the left side, seem to be associated
with additional psychiatric problems and are not al-
ways easily controlled by antiepileptic medication, as
was seen in one of our subjects. Two of the three
who developed epilepsy before the age of 5 in this
study stopped having fits by the age of 20. This benign
course of the seizures in fragile X syndrome suggests a
maturational process and has been compared to similar
phenomenon seen in Benign Childhood Epilepsy with
Centro-temporal Spikes (BCECS)22. A study by Wis-
niewski5 reported Rolandic spikes typical of BCECS
in four individuals with fragile X syndrome (with and
without epileptic seizures), with seizures in two of
them disappearing at a later age. It was hypothesized
from all these findings that an age-related matura-
tional process is evident in fragile X similar to that in
BCECS. It has been suggested that the locus for fragile
X and BCECS could be the same, although in BCECS
there is no additional neurological, psychiatric, or be-
havioural handicap, and there is a strong family history
of an autosomal dominant inheritance.
However, unlike the findings of Wisniewski5,
epilepsy in our sample did not have a benign course
in all the cases. Half of our sample continued to have
seizures after the age of 20. While two showed no
change, epilepsy in one individual deteriorated.
Follow up of the EEG activities over a period of
time in this study revealed that only 4/9 (44%) showed
improvement. Four individuals (44%) showed no im-
provement and one (12%) showed deterioration. The
course of epileptic seizures in fragile X syndrome
seems to be variable.
We saw bilateral rhythmic theta/delta activity in
50% of subjects in this study. The only previous report
of this in association with fragile X is by Wisniewski5.
It was noted in that study that the most common con-
stellation of abnormalities in a group of non-epileptic
fragile X subjects is a slow background rhythm and
abnormal intermittent rhythmic theta or delta activity.
The significance of excess rhythmic theta activity and
slowing of background activity in the EEG is not clear.
Only two of the four individuals who had sleep
EEGs showed abnormalities. They did not reveal
the characteristic sleep EEG patterns proposed by
Musumeci22. While most of the studies on sleep EEG
have used one or other medications, in two of our
patients this was achieved without any medication.
However it is difficult to draw any conclusions in view
of the small sample size.
One feature that has been found consistently in the
literature is a slowing of background activity in EEGs
of people with fragile X (see Table 1). Vieregge and
Froster-Iskenius21 felt this feature suggests immatu-
rity in children and slight abnormality in adults. Slow-
ing of background activity was seen in 5/18 (27.75%)
in our study.
There have been different theories proposed to ex-
plain the incidence of epilepsy and EEG changes in
fragile X syndrome. Vieregge and Froster-Iskenius21
suggested the dendritic spine abnormalities observed
in fragile X syndrome as the cause of excessive neu-
ronal excitation and spiking. Another possible cause
could be the deficits of GABA neurones in the cere-
bellar vermal region. Binstock26 has proposed that it
is the absence of the FMR protein that leads to a dys-
function in the GABAnergic system. Kluger27, who
performed EEGs on children with fragile X and ge-
netic analysis on children with BCECS, has suggested
that the final common pathway of impairment in the
two conditions is the FMR-1 gene.
CONCLUSIONS
The findings from this study indicate that the natu-
ral history of epilepsy in fragile X is more variable
than previously thought. A significant proportion of
our patients either continued to have seizures until a
later age or developed late onset epilepsy. Contrary
to the previous findings that most fragile X individu-
als with epilepsy have generalized seizures, our study
found partial epilepsy to be as frequent as generalized.
The EEG pattern of episodic theta activity has been
Epilepsy and EEG in fragile X 63
reported in only one study before5.
Ours was a qualitative longitudinal study with no
age/sex/IQ-matched controls. Future studies with con-
trol groups of IQ-matched non-fragile X individuals,
prospective EEG recordings, and DNA analysis will
shed more light on the role of the FMR-1 gene in the
evolution of epilepsy in fragile X syndrome.
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